Progress in treatment strategies of patients with acute coronary

doi:10.3969/j.issn.1004-583X.2016.06.005

Abstract

Abstract:

Chronic kidney disease (CKD) is an independent risk factor of cardiovascular disease (CVD)， and CVD is the main cause of death in CKD. Because of the increased risk of bleeding in patients with CKD and acute coronary syndrome(ACS)， the basic treatment of drugs and other therapeutic measures are reduced， especially percutaneous coronary intervention treatment， which is associated with increased morbidity and mortality. This review systematically focuses on the pathogenesis， clinical characteristics and treatment strategies in patients with ACS and CKD.

Key words: acute coronary syndrome, kidney disease, percutaneous coronary intervention

Liu Jinming， Li Fang， Xie Yanan. Progress in treatment strategies of patients with acute coronary[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2016.06.005.

Add to citation manager EndNote|Ris|BibTeX

URL: https://lchc.magtechjournal.com/EN/10.3969/j.issn.1004-583X.2016.06.005

https://lchc.magtechjournal.com/EN/Y2016/V31/I6/600

[1]	Chen Tianhao, Huang Zheng. Clinical significance of serum vitamin K₂ detection in patients with stage 3-5 chronic kidney disease [J]. Clinical Focus, 2025, 40(2): 122-127.
[2]	Zhang Lei, Li Xin, Guo Zhenfeng. Efficacy and safety of intracoronary injection of teneplase versus tirofiban on the treatment of acute ST-segment elevation myocardial infarction [J]. Clinical Focus, 2024, 39(7): 598-602.
[3]	Wang Zhongqi, Li Jinzhao, Wu Nan. Correlation between systemic immune inflammation index and multivessel coronary disease in patients with acute coronary syndrome [J]. Clinical Focus, 2024, 39(6): 512-517.
[4]	Li Yanan, Zhang Hongyu. Clinical study of the efficacy of intracoronary injections of low-dose prourokinase through the tail of the balloon on acute ST-segment elevation myocardial infarction patients undergoing percuteneous coronary intervention [J]. Clinical Focus, 2024, 39(6): 518-523.
[5]	Yang Xingmeng, Ma Xiaoying, Sheng Yuping, Liu Ye, Zhang Haoran, Xu Haiping, Wang Na, Sun Fuyun. Correlation between homocysteine and abdominal aortic calcification in non-dialysis patients with stage 5 chronic kidney disease [J]. Clinical Focus, 2024, 39(1): 30-33.
[6]	Yan Haiyan, Ding Yankui, JiaHongjing , WangJiyuan , Zhang Xuewei, Hu Yinjie, Chu Junjie, Hu Hongyan, Guo Gaofeng. Correlation of pre-hospital heparinization combined with one pack of drugs and revascularization in patients with acute ST-segment elevation myocardial infarction [J]. Clinical Focus, 2023, 38(3): 232-236.
[7]	Wang Jiaqi, Gao Man, Zhang Feifei, Li Yingxiao, Dang Yi, Qi Xiaoyong. Predicting value of neutrophil to lymphocyte ratio combined with GRACE score on in-hospital major adverse cardiovascular events of postoperative PCI in acute STEMI patients [J]. Clinical Focus, 2022, 37(5): 412-417.
[8]	Li Jianqin, Sheng Yueyue, Zhou Yinmin, Shi Weiqing, Yang Xingchen. Safety of clopidogrel combined with statins on acute coronary syndrome in patients based on metabolic pathways by different cytochrome P450 enzyme: a Meta analysis [J]. Clinical Focus, 2022, 37(2): 101-105.
[9]	Deng Kaibin, Han Liang, Niu Shaoqian, Wang Haiyan, Wang Yanbo, Fu Yang, Wang Qing, Zhan Yang, Fu Xianghua. Effect of optimized treatment approach on acute STEMI patients under the situation of prevention and control of COVID-19 [J]. Clinical Focus, 2021, 36(7): 595-599.
[10]	Shi Jun, Liu Xinbing, Bai Yanyan, Yue Dandan, Wang Xiaoqing, Liu Tianhua, Feng Liuliu. Influencing factors of myocardial microcirculation perfusion disorder after percutaneous coronary intervention in acute myocardial infarction and relationship with lactic acid [J]. Clinical Focus, 2021, 36(5): 402-407.
[11]	Cui Guoyan, Zheng Wen, Zhang Liwei. Clinical efficacy of lidocaine combined with rosuvastatin in treating acute coronary syndrome concurrent with acute arrhythmia among patients intolerant of amiodarone [J]. Clinical Focus, 2021, 36(4): 311-314.
[12]	Gao Xinglian, Tong Zongwu, Yang Chongmeng, Zhao Yanhong, Lu Yongxin, Ding Rong. A case of AL type amyloidosis nephropathy treated with sequential chemotherapy [J]. Clinical Focus, 2021, 36(3): 266-269.
[13]	Liu Yuanliang, Li Biao, Jiang Zuofeng, Zhu Youfeng, Zhang Shaoheng, Wang Yarong, Li Rongseng, Li Li. Efficacy and safety of half-dose versus standard-dose of tirofiban for percutaneous coronary intervention in elderly Chinese patients with acute coronary syndrome: a meta-analysis [J]. Clinical Focus, 2021, 36(11): 965-971.
[14]	Wang Chao, Wan Duo, Li Sali, Wang Xi. Evaluation of carotid Doppler ultrasonography in degree and hemodynamics of atherosclerosis of chronic kidney disease [J]. Clinical Focus, 2021, 36(11): 1009-1012.
[15]	Zhou Jing, Dai Yunlang. Clinical characteristics and prognosis of patients with isolated left main stenosis in coronary intervention [J]. Clinical Focus, 2021, 36(1): 12-15.

Progress in treatment strategies of patients with acute coronary

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments